--- source_url: https://hangovr180.com/science/claims/inflammation-response.md canonical_url: https://hangovr180.com/science/claims/inflammation-response generated_at: 2026-06-28T19:53:17Z build_id: ebfcfef page_type: science-leaf claim_ids: [SF-17, SF-33, SF-26] --- # THE INFLAMMATION RESPONSE CLAIM *Alcohol metabolism triggers a measurable inflammatory cytokine response in liver tissue, and the H180 inflammation response claim ties to the anti-inflammatory effects of DHM and the antioxidant role of glutathione documented in the published animal literature.* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. ## What the Inflammatory Response to Alcohol Looks Like Alcohol metabolism in the liver triggers a measurable inflammatory response. The mechanism involves several layers running at the same time: acetaldehyde directly modifies cellular proteins through adduct formation, the resulting damaged proteins activate immune signaling, gut barrier function deteriorates with alcohol exposure (allowing bacterial endotoxin into portal circulation), and Kupffer cells in the liver respond by releasing pro-inflammatory cytokines including TNF-alpha, IL-6, and IL-17 [1]. This inflammatory cascade is part of why hangover symptoms involve more than just acetaldehyde load. The cytokine response itself produces malaise, cognitive fog, and the broader feeling of being unwell that lingers after alcohol clears. ## What DHM Does to the Inflammatory Response > **Claim [SF-17]:** Supports a healthy inflammation response. † > > † These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. DHM administration in animal models reduces the major pro-inflammatory cytokines associated with alcohol-induced liver pathology. A 2023 study examining DHM and ethanol-induced liver outcomes reported that DHM significantly reduced hepatic TNF-alpha, IL-6, and IL-17 expression at multiple doses [1]. A separate 2024 study on DHM in non-alcoholic fatty liver disease demonstrated similar anti-inflammatory effects through modulation of gut microbiota and inflammatory signaling pathways [2]. The cytokine reduction effect is documented across multiple animal models, in the published rodent data at least. > **Claim [SF-33]:** Calm your body's reactions, reducing occasional inflammation. † > > † These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. (this is one of the claims where the underlying mechanism literature is broader than what the regulatory framing allows us to say on the label, which is fine because the bounded version is still defensible.) ## The Neuroinflammation Side > **Claim [SF-26]:** Protects against occasional neuroinflammation. † > > † These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. DHM's anti-inflammatory effects also extend into the brain. In APP/PS1 transgenic mice (an Alzheimer's disease model), DHM suppressed activation of the NLRP3 inflammasome in microglia and reduced markers of neuroinflammation [3]. The neuroinflammation claim ties specifically to this microglial-suppression mechanism. ## The Fulvic Acid Contribution The fulvic acid in the H180 formula has its own anti-inflammatory profile. The 2018 review of fulvic acid's therapeutic potential in chronic inflammatory disease covers anti-inflammatory effects, modulation of immune signaling, and antioxidant capacity [4]. Fulvic acid is in the formula primarily as a delivery agent rather than as a primary anti-inflammatory ingredient, but the secondary effect aligns with the overall direction the formula is pushing. ## What This Page Is Not Claiming The inflammation response claim is bounded ot occasional inflammatory load from food and drink, not chronic inflammatory disease. We do not claim H180 treats arthritis, autoimmune conditions, or any chronic inflammatory state. The claim is what the published animal mechanism literature supports for occasional dietary inflammatory triggers (including alcohol), framed in DSHEA-compliant terms. For the upstream oxidative-stress story that drives a lot of the inflammatory response, see [ROS and Oxidative Stress](/science/sag/ros-oxidative-stress). For the closely related neuroinflammation evidence in DHM, see [The Brain Aging Claim](/science/claims/brain-aging-claim). ## Citations 1. [Dihydromyricetin Supplementation Improves Ethanol-Induced Lipid Accumulation and Inflammation](https://pmc.ncbi.nlm.nih.gov/articles/PMC10481966/). pmc.ncbi.nlm.nih.gov. 2. [Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways](https://pmc.ncbi.nlm.nih.gov/articles/PMC11729546/). pmc.ncbi.nlm.nih.gov. 3. [Dihydromyricetin Inhibits Microglial Activation and Neuroinflammation by Suppressing NLRP3 Inflammasome Activation in APP/PS1 Transgenic Mice](https://pmc.ncbi.nlm.nih.gov/articles/PMC6282966/). pmc.ncbi.nlm.nih.gov. 4. [Therapeutic Potential of Fulvic Acid in Chronic Inflammatory Diseases and Diabetes](https://pmc.ncbi.nlm.nih.gov/articles/PMC6151376/). pmc.ncbi.nlm.nih.gov. ## Read Next - [ROS and Oxidative Stress](/science/sag/ros-oxidative-stress) - [DHM and Brain Aging](/science/dhm/brain-aging) - [The Brain Aging Claim](/science/claims/brain-aging-claim) - [The Claims -- The Hub](/science/claims) **Written by Mark Scott** - Co-Formulator, Hangovr180® | Co-Inventor, [US Application 18/698,010](https://patents.google.com/patent/US20250073201A1) Mark Scott conducted approximately 150 personal formulation tests over six months to develop the H180 ingredient combination. [Editorial standards](/editorial-standards) --- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Hangovr180® is a dietary supplement. Individual results may vary. Consult your healthcare provider before use if you have any medical conditions or take medications. [US Application 18/698,010](https://patents.google.com/patent/US20250073201A1). Canonical: https://hangovr180.com/science/claims/inflammation-response